Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
NZ shares hit record, led by Pushpay

53m nzherald.co.nz
New Zealand shares hit another record amidst a slew of earnings, with Trade Me Group and A2 Milk Co gaining on their annual accounts while Fletcher Building dropped.
TME TRMEF FBU WBC FCREY SPKKY NZTCY SPK NZTCF WEBNF WBK FRCEF WBC PPSHY FBU TME TDMEY MEZ

0
NZ dollar climbs above 67 US cents on strong retail sales

1h nzherald.co.nz
The New Zealand dollar climbed above 67 US cents as stronger than expected consumer spending added to already increased demand for risk-sensitive assets.
WBC WBC WEBNF WBK

0
'Australia's Most Trusted Bank' Offers A 6% Yield But Wait Until You Jump In

15h seekingalpha
Editor's note: Seeking Alpha is proud to welcome Benjamin Sygo as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
NAUBF NAB NASXF NABZY WBK BXRBY BXRBF

0
NZ dollar benefits from USD weakness

2018-08-21 nzherald.co.nz
The New Zealand dollar gained as the greenback continued to be weighed down in Asian trading by complaints US President Donald Trump made about US interest rate rises.
WBC WBC WEBNF WBK

0
More Kiwis cross the ditch as net migration slows

2018-08-21 nzherald.co.nz
New Zealand's inbound net migration continued to slow from a peak last year as a growing number of long-term visitors leave the country, on top of more Kiwis departing for Australia.
WBC WBC WEBNF WBK

0
WBK / Westpac Banking Corp. Ltd. 6-K (Current Report of Foreign Issuer)

2018-08-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
WBK

0
Hong Kong intervenes to defend peg for first time since May

2018-08-15 malaymail
HONG KONG, Aug 15 — Hong Kong intervened to defend its peg to the US dollar for the first time in three months after the local currency fell to the weak end of its trading band.
WBC WEBNF WBK HCS HSB 0005 WBC HSEA HSEB HSBC HBCYF

0
New Zealand Poised to Crack Down on Foreign Home Buyers

2018-08-15 theedgemarkets
(Aug 15): New Zealand’s government is poised to ban foreigners from buying residential property, making good on its promise to crack down on offshore speculators who it says are partly to blame for spiraling house prices.
WBC WBC WEBNF WBK

0
Electronic cards spending climbs in July

2018-08-09 nzherald.co.nz
New Zealand retail spending on electronic cards rose in July as the government's suite of measures aimed at boosting household incomes came into effect.
WBC WBC WEBNF WBK

0
NZ dollar tumbles against trading partners

2018-08-09 nzherald.co.nz
The New Zealand dollar tumbled 1.2 percent against its trading partners and interest rate swaps fell after the Kiwi central bank said rates would stay at record lows for up to a year longer than previously indicated.
WBC WBC WEBNF WBK

0
It's the Politics Stupid! Jobs Risk for Australia's Central Bank - Bloomberg

2018-08-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WBC WBC WEBNF WBK

0
Australia grants invasive new power to financial regulator

2018-08-07 theedgemarkets
SYDNEY (Aug 7): Australia on Tuesday granted the corporate watchdog invasive new power to position supervisors inside financial firms after a public inquiry exposed systemic wrongdoing at some of the country's top institutions.
NAUBF WBC WBC NAB NASXF AMP WEBNF NABZY WBK

0
Sydney’s Housing Slide Is One More Reason for Rates to Stay on Hold - Bloomberg

2018-08-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WBC WBC WEBNF MS WBK

0
Australia calls on bank outsiders to break up Big Four dominance

2018-08-03 theedgemarkets
SYDNEY (Aug 3): Australia's government called for more banks to challenge the industry's oligopoly on Friday, after the country's top economic adviser said the "Big Four" lenders' market dominance has been detrimental to customers.
NAUBF WBC WBC NAB NASXF WEBNF NABZY WBK

11
30 'Safer' Dividend Financial WallStars Show 3.5-13.7% Yields For Dog Days

2018-07-31 seekingalpha
WallStars are distinguished by positive broker target price upsides. Top 10 Financial Services 'safer' dividend WallStars, MET, SAN, VLY, BCBP, PRU, HSBC, VIRT, TCRD, MVC, and DGICA averaged 24% net.
AIY AINV MET MVC SANT PRU HSB MVCD MVCB HSBC AB SAN HBCYF PRU TCRX WBC BCBP PFK WEBNF AIB WBK TCRD HCS TCRZ TSLF OCSI BNC 0005 WBC PRH VIRT HSEA HSEB DGICA DGICB PJH IVZ

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 961214301